Expression levels of DNA damage repair proteins are associated with overall survival in platinum-treated advanced urothelial carcinoma Journal Article


Authors: Mullane, S. A.; Werner, L.; Guancial, E. A.; Lis, R. T.; Stack, E. C.; Loda, M.; Kantoff, P. W.; Choueiri, T. K.; Rosenberg, J.; Bellmunt, J.
Article Title: Expression levels of DNA damage repair proteins are associated with overall survival in platinum-treated advanced urothelial carcinoma
Abstract: Micro-Abstract In a cohort of 104 patients with metastatic urothelial carcinoma (mUC) who had received platinum therapy, we examined the correlation between ERCC1, RAD51, PARP-1, PAR, BRCA1, and BRCA2 and overall survival (OS). A greater percentage of nuclear staining of ERCC1 (hazard ratio [HR], 2.7; 95% confidence interval [CI], 1.5-4.9; P =.0007), RAD51 (HR, 5.6; 95% CI, 1.7-18.3; P =.005), and PAR (HR, 2.2; 95% CI, 1.1-4.4; P =.026) was associated with worse OS. © 2015 Elsevier Inc.
Keywords: immunohistochemistry; dna damage; bladder cancer; platinum chemotherapy
Journal Title: Clinical Genitourinary Cancer
Volume: 14
Issue: 4
ISSN: 1558-7673
Publisher: Elsevier Inc.  
Date Published: 2016-08-01
Start Page: 352
End Page: 359
Language: English
DOI: 10.1016/j.clgc.2015.12.029
PROVIDER: scopus
PUBMED: 26778300
PMCID: PMC5508512
DOI/URL:
Notes: Article -- Export Date: 1 November 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg